Breaking News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

MetLife Upset With Federal Reserve Over Stress Test Results - Update

RELATED NEWS
Trade MET now with 
3/13/2012 7:41 PM ET

MetLife Inc. (MET: Quote) Tuesday played down the results from the latest round of stress tests by the Federal Reserve, stating that its financial position remained strong and is capable of meeting an adverse economic scenario.

The Federal Reserve earlier in the day revealed results from its stress tests, or Comprehensive Capital Analysis and Review, of 19 biggest U.S. banks, including MetLife, to assess their financial soundness to return more capital to shareholders.

Results from the tests showed that MetLife will not be able to maintain its core tier-one capital ratio at above 5 percent of risk-weighted assets, prompting the Federal Reserve to deny a request by the insurer for an increase in its capital distribution plan.

Expressing displeasure, MetLife CEO Steven Kandarian said that bank-centric methodologies used under the stress tests are unsuitable for insurance companies, which have a different business model.

Kandarian said that when gauged under methodologies apt for insurers, MetLife has an enviable financial position. He indicated that at the end of 2011, MetLife had a consolidated risk-based capital ratio of 450 percent.

In its capital plan submitted to the Federal Reserve, MetLife had requested for approval of $2 billion in stock repurchases and a raise in its annual common stock dividend to to $1.10 per share from $0.74 per share.

MetLife had excess capital of $3.5 billion at the end of 2011, and expects that to reach $6 billion to $7 billion by the end of 2012, before any capital distribution actions.

Apart from MetLife, the Federal Reserve said that Citigroup, SunTrust and Ally would all see their capital ratio fall below 5 percent if they went ahead with their capital plans. But most of the banks subject to the stress tests were allowed to raise dividends and buy back shares.

The Federal Reserve had asked these banks to evaluate their financial strength amid a global economy bogged down by recession and double-digit unemployment in the U.S. Only those banks that can prove their ability to maintain core capital levels above 5 per cent of risk-weighted assets are allowed to raise dividends and buy back shares.

J.P. Morgan Chase & Co. was the first institution to disclose its results. The bank said it would increase its quarterly dividend to 30 cents, and repurchase about $15 billion of stock over the next year.

MET closed Tuesday on the NYSE at $39.46, up $1.78 or 4.72%, on a volume of 12.2 million shares. In after hours, the stock dropped 3.7%.

Register
To receive FREE breaking news email alerts for MetLife Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
There was a mixed performance on Wall Street on Friday. Shares suffered an early decline, as investors continued to express worries about the Federal Reserve. A recovery through the rest of the day allowed the Dow to edge into positive territory by the close. The Nasdaq and S&P 500 posted fractional losses. Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session. After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.